bioRxivCancer Biology
Enhancer hijacking determines intra- and extrachromosomal circular MYCN amplicon architecture in neuroblastoma
K. Helmsauer, M. Valieva, S. Ali, R. Chamorro Gonzalez, R. Schoepflin, C. Roeefzaad, Y. Bei, H. Dorado Garcia, E. Rodriguez-Fos, M. Puiggros, V. Heinrich, M. Robson, K. Kasack, K. Haase, L. P. Kuschel, P. Euskirchen, C. Rosswog, J. Toedling, A. Szymansky, F. Hertwig, M. Fischer, D. Torrents, A. Eggert, J. H. Schulte, S. Mundlos, , R. P. Koche
Abstract
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA. The exact amplicon structure has not been described thus far and the functional relevance of its rearrangements is unknown. Here, we analyzed the MYCN amplicon structure and its chromatin landscape. This revealed two distinct classes of amplicons which explain the regulatory requirements for MYCN overexpression. The first class always co-amplified a proximal enhancer driven by the noradrenergic core regulatory circuit (CRC). The second class of MYCN amplicons was characterized by high structural complexity, lacked key local enhancers, and instead contained distal chromosomal fragments, which harbored CRC-driven enhancers. Thus, ectopic enhancer hijacking can compensate for the loss of local gene regulatory elements and explains a large component of the structural diversity observed in MYCN amplification.
- organism: human
- assay: DNA methylation
- assay: ChIP-seq
- research focus: chromatin & epigenetic regulation
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A "cooperative collaboration" between HAND2 and MYCN shapes neuroblastoma cell identity
- 5-hydroxymethylcytosine deposition mediates Polycomb Repressive Complex 2 function in MYCN-amplified neuroblastoma
Mohansrinivas Chennakesavalu, Gabriel L. Lopez, … Mark A. Applebaum·iSciencePeer-reviewed·Jul 16, 2026
- Quantitative and sensitive neuroblastoma minimal residual disease detection using extrachromosomal DNA (ecDNA) breakpoints
Annabell Szymansky, Falk Hertwig, … Johannes Hubertus Schulte·bioRxiv·Sep 12, 2026
- Intercellular extrachromosomal DNA copy number heterogeneity drives cancer cell state diversity
M. C. Stoeber, R. Chamorro Gonzalez, … K. Haase·bioRxiv·Jan 21, 2023
- A Quantitative Analysis of Localized Robustness of MYCN in Neuroblastoma
Romeil Sandhu, Sarah Tannenbaum, … Allen Tannenbaum·bioRxiv·Jan 22, 2016
- METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma
K. Thombare, R. Vaid, … T. Mondal·bioRxiv·Oct 6, 2023